Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ross Acquisition Corp II Cl A (ROSS)

Ross Acquisition Corp II Cl A (ROSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 151,419
  • Shares Outstanding, K 13,666
  • Annual Sales, $ 0 K
  • Annual Income, $ 14,870 K
  • 60-Month Beta 0.02
  • Price/Sales N/A
  • Price/Cash Flow 6.43
  • Price/Book N/A
Trade ROSS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-6770 Blank Checks

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.98 +0.91%
on 02/20/24
11.12 -0.36%
on 03/14/24
+0.08 (+0.76%)
since 02/15/24
3-Month
10.79 +2.69%
on 12/20/23
11.12 -0.36%
on 03/14/24
+0.20 (+1.84%)
since 12/15/23
52-Week
10.21 +8.52%
on 03/28/23
11.12 -0.36%
on 03/14/24
+0.86 (+8.41%)
since 03/15/23

Most Recent Stories

More News
APRINOIA Therapeutics and ROSS Acquisition Corp II Announce Business Combination Agreement to Create Publicly Listed Company Focused on Neurodegenerative Diseases

ROSS SPAC will issue $280 million of stock for APRINOIA Therapeutics Precision Neurology Company Focused on Developing a Pipeline of Highly Specific Central...

ROSS : 11.08 (-0.36%)
5 Best Stocks in Nasdaq ETF That Gained in April

The tech-heavy Nasdaq Composite Index logged in the worst month since 2008, having fallen 15%.

CEG : 184.85 (-0.02%)
VRTX : 418.01 (+0.17%)
QQQ : 444.01 (-0.18%)
MNST : 59.28 (+0.14%)
KHC : 36.90 (+1.01%)
ROSS : 11.08 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar